Nascent Biotech Inc's ROI from its first quarter of 2025 to the first quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nascent Biotech Inc's ROI in the first quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Nascent Biotech Inc 's return on investment (ROI) in its first quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2024) I. Quarter	(Mar 31 2024) IV. Quarter	(Dec 31 2023) III. Quarter	(Sep 30 2023) II. Quarter	(Jun 30 2023) I. Quarter
Y / Y Investment Change TTM	-	-	-	-	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	-1	0	0	0	-1
Return On Investment (TTM)	-	-	344.95 %	-	-
NBIO's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-2	-2	-2	-3	-2

NBIO Company Profile >> Back to NBIO Roi Comparisons >> See Annual NBIO Return On Investment

Return On Investment NBIO's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Nascent Biotech Inc's I. Quarter Investments	$ -1 Millions	NBIO's Balance sheet
Nascent Biotech Inc's I. Quarter Income	$ 0 Millions	Quarterly NBIO's Income Statement
NBIO's Income by Division		See NBIO's Income by Division

NBIO Annual Return On Investment	(Mar 31 2024) 2024	(Mar 31 2023) 2023	(Mar 31 2022) 2022	(Mar 31 2021) 2021	(Mar 31 2020) 2020
Total Investments in Millions	0	-1	-1	0	-3
Y / Y Investment Growth	-	-	-	-	-
Net Income in Millions	-2	-3	0	-1	-4
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NBIO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NBIO's Competitors
Subscribers only: Roi for Nascent Biotech Inc's Suppliers
Subscribers only: Return On Investment for NBIO's Customers

Other Ratios
NBIO's Roa	NBIO's Inventory Turnover Ratio	NBIO's Growth Rates	NBIO's Dividend Statistics
	NBIO's Profitability Ratios	NBIO's Asset Turnover Ratio	NBIO's Dividend Growth
NBIO's Roe	NBIO's Valuation Ratios	NBIO's Financial Strength Ratios	NBIO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2024, within Healthcare Sector	ROI
Orgenesis Inc	1,928.05 %
Glucotrack Inc	718.82 %
Traws Pharma inc	713.09 %
Longduoduo Co Ltd	582.27 %
Inhibrx Biosciences Inc	454.71 %
Ir med Inc	433.31 %
Kaya Holdings Inc	415.17 %
Interpace Biosciences Inc	243.24 %
WEED, INC.	238.52 %

Date modified: 2026-09-08T15:11:18+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.